Page last updated: 2024-09-03

validol and Adenocarcinoma

validol has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fang, J; Feng, Y; Gu, H; Huang, L; Huang, T; Jiang, M; Li, B; Pi, C; Xie, K; Xu, L; Xu, X; Zhang, J	1

Other Studies

1 other study(ies) available for validol and Adenocarcinoma

Article	Year
Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression. International immunopharmacology, 2021, Volume: 101, Issue:Pt B Topics: Adaptation, Physiological; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Immunosuppression Therapy; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Neoplasms, Experimental; Programmed Cell Death 1 Receptor; Specific Pathogen-Free Organisms; Tumor Microenvironment; Up-Regulation; Valerates	2021

Article

Year

Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression.

International immunopharmacology, 2021, Volume: 101, Issue:Pt B

Topics: Adaptation, Physiological; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Immunosuppression Therapy; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Neoplasms, Experimental; Programmed Cell Death 1 Receptor; Specific Pathogen-Free Organisms; Tumor Microenvironment; Up-Regulation; Valerates

2021